Safety and Efficacy of Canagliflozin in Advanced CKD
ACTIVE_NOT_RECRUITING
Status
Conditions
- ESRD
- CKD Stage 4
- CKD Stage 5
Interventions
- DRUG: Invokana 300 mg and 100 mg tablet
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre